Intensity Therapeutics(INTS) - 2025 FY - Earnings Call Transcript

Financial Data and Key Metrics Changes - The meeting confirmed that a majority of votes were cast in favor of the reverse stock split proposal and the adjournment proposal, indicating shareholder support for these strategic decisions [8]. Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting. Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting. Company Strategy and Development Direction - The company intends to implement a reverse stock split by a ratio of not less than one for five and not more than one for thirty, with the exact ratio to be determined by the Board of Directors [5]. Management's Comments on Operating Environment and Future Outlook - Management indicated that the decision regarding the reverse stock split will be made at a time deemed necessary by the Board of Directors, emphasizing the flexibility in timing [9]. Other Important Information - The meeting was held virtually to enhance accessibility for shareholders, and a quorum was established with 22,631,128 shares present, representing 46.13% of the outstanding voting stock [4]. Q&A Session Summary Question: When would the company decide to do the reverse stock split and what number of shares would be reduced to? - Management stated that the decision will be determined by the Board of Directors in their sole discretion, with the implementation occurring before the deadline if the vote is favorable [9].